NEVVI Medicare utilization intelligence

← back

HAGGERTY, JOSEPHM.D. NPI 1013098870 Clinician

Hematology-Oncology · ROCKVILLE, MD

Specialty Hematology-Oncology — from billed Medicare claims
Trained VIRGINIA COMMONWEALTH UNIVERSITY, SCHOOL OF MEDICINE — medical school, self-reported to CMS
In practice about 44 years since medical school (class of 1982, self-reported to CMS)
Location ROCKVILLE, MD · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 41 codes billed · 28,259 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
MARYLAND ONCOLOGY HEMATOLOGY PA
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2010-06

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J0185 Injection, aprepitant, 1 mg
J0897 Injection, denosumab, 1 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
J1100 Injection, dexamethasone sodium phosphate, 1 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J0640 Injection, leucovorin calcium, per 50 mg
J1626 Injection, granisetron hydrochloride, 100 mcg
J2469 Injection, palonosetron hcl, 25 mcg
82784 Gammaglobulin (immune system protein) measurement
J9190 Injection, fluorouracil, 500 mg
82728 Ferritin (blood protein) level
83540 Iron level
83550 Iron binding capacity
82378 Carcinoembryonic antigen (cea) protein level
96375 Injection of additional new drug or substance into vein
96413 Administration of chemotherapy into vein, 1 hour or less
96372 Injection of drug or substance under skin or into muscle
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
83520 Measurement of substance using immunoassay technique
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
82232 Beta-2 microglobulin (protein) level
85651 Red blood cell sedimentation rate, to detect inflammation, non-automated
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
36415 Insertion of needle into vein for collection of blood sample
J1200 Injection, diphenhydramine hcl, up to 50 mg
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
83615 Lactate dehydrogenase (enzyme) level
96417 Administration of additional new drug or substance into vein, 1 hour or less
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
96415 Administration of chemotherapy into vein, each additional hour
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
J7030 Infusion, normal saline solution , 1000 cc
J3490 Unclassified drugs
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
96360 Infusion into a vein for hydration, 31-60 minutes
96361 Infusion into a vein for hydration, each additional hour

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.